methocarbamol · Rosemont Pharms · NDA 219843
Atmeksi
Earliest generic entry, as listed
9 Oct 2044
Blocked by patent: US 12390439.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12390439 | product, use U-4253 | 9 Oct 2044 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 219843 · 001 · RLD | suspension, oral | 750MG/5ML | 9 Oct 2044 |